Cardiology
RSSArticles
-
Is Earlier Better With Oral P2Y12 Inhibition in STEMI Patients?
In a large retrospective analysis of patients in Sweden treated with primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction, a propensity-matched group of patients who received oral P2Y12 inhibitors at initial medical contact did not show improved outcomes vs. those receiving these agents at the time of PCI.
-
Early vs. Delayed Cardioversion: A Nonshocking Result
For patients presenting to an ED with recent-onset atrial fibrillation, using rate control and outpatient cardioversion only as needed was associated with a high rate of spontaneous conversion within 48 hours of arrhythmia onset and noninferior short-term outcomes compared to immediate cardioversion in the ED.
-
Reader Survey Available
We'd love to hear from you how we can do better!
-
Efficacy of Preoxygenation Methods Prior to Endotracheal Intubation
A post-hoc analysis of data from the MACMAN trial revealed noninvasive ventilation may be the preferred preoxygenation approach for intubation, especially in the setting of severe hypoxemia.
-
Medication Errors When Patients Transition Out of ICU
Three factors associated with decreased odds of an error occurring were daily patient care rounds in the ICU, discontinuing and rewriting medication orders during the transition of care from the ICU to a non-ICU setting, and 16-20 ICU beds in the transferring ICU.
-
Timing of Initiation of Renal Replacement Therapy in the ICU
Acute kidney injury is common in patients admitted to the ICU and is associated with high mortality. The decision to initiate renal replacement therapy (RRT) for these patients is complicated. Not only is the optimal time for starting therapy unclear, decisions to transfer patients to higher levels of care often are driven by the perceived need to initiate hemodialysis or continuous RRT.
-
Why Is the QRS Wide?
The ECG in the figure belongs to an older woman who called EMS because of new-onset chest pain. How might one interpret the tracing? Why is the QRS complex wide?
-
Erdafitinib Tablets (Balversa)
Erdafitinib is the first FDA-approved targeted therapy for metastatic bladder cancer.
-
The Promise and Perils of the Apple Heart Study
A large study with virtual enrollment of Apple Watch users helped illustrate the positive predictive value of wearable, pulse-based atrial fibrillation detection technology, as well as the ability to enroll and follow huge numbers of research subjects in a short period.
-
How Safe Are New Medications for Type 2 Diabetes?
In recent years, new medications have been approved for the management of type 2 diabetes, generally after metformin is given. The FDA has reported 55 cases of Fournier’s gangrene in patients using SGLT2 inhibitors. These medications may not be worth the risk when lifestyle alternatives are available.